Guidance and safety warnings for the use of Eltrombopag/Eltrombopag in pregnant women, children and other special groups

Eltrombopag/Eltrombopag, as an effective drug for the treatment of idiopathic thrombocytopenic purpura (ITP), can significantly increase the number of platelets by stimulating platelet production in the bone marrow, thereby alleviating the clinical symptoms of patients. However, for special groups such as pregnant women and children, you must be extra careful when using eltrombopag and strictly follow the doctor's instructions and precautions.

For pregnant women, current data are insufficient to assess the possible risk of eltrombopag to the fetus. Animal studies have shown that in pregnant rats, oral administration of eltrombopag resulted in embryonic lethality and fetal weight loss at maternally toxic doses. Therefore, women of childbearing potential should use effective contraceptive measures during treatment and for at least 7 days after discontinuation of treatment. At the same time, breastfeeding is not recommended during treatment. If possible, alternative treatments should be preferred to manage ITP.

For children, the safety and efficacy of eltrombopag have been demonstrated inchildren aged 1 year and older with persistent or chronic ITP and children 2 years and older with severe aplastic anemia who have not been treated with standard immunosuppressive therapy (IST). However, the safety and efficacy of eltrombopag have not been established in pediatric patients younger than 1 year of age and in pediatric patients with chronic hepatitis C and refractory severe aplastic anemia-associated thrombocytopenia. When using eltrombopag, doctors usually determine the dose based on the child's age, weight and clinical condition, and closely monitor platelet counts and side effects.

In summary, caution is required when using eltrombopag in special populations. Pregnant women should avoid use, while use in children requires careful evaluation of the risks and benefits of the drug. Always use eltrombopag under your doctor's supervision and follow your doctor's recommendations and precautions.